Insulinotropic and glucagonotropic effects of beta-lactoglobulin
AU2026220258A1Pending Publication Date: 2026-09-10ARLA FOODS AMBA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026220258
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-08-20
- Publication Date
- 2026-09-10
Smart Images
Figure 00000092_0000 
Figure 00000093_0000 
Figure 00000094_0000
Abstract
The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition compris- ing beta-lactoglobulin for use in preventing and / or treating a metabolic disorder and / or muscle atrophy. It also pertains to a method of preventing and / or treating a metabolic disorder and / or 5 muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nu- tritional composition comprising beta-lactoglobulin for increasing the level of insulin and / or glu- cagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin or b) a nutritional composition comprising BLG. It also per- tains to beta-lactoglobulin (BLG) for use in preventing and / or treating diabetes or prediabetes 10 in a subject. It furthermore pertains to a nutritional composition for use in preventing and / or treating diabetes or prediabetes in a subject. 5 20 26 22 02 58 20 A ug 2 02 6 A u g 5
Need to check novelty before this filing date? Find Prior Art